EPL Lab received ISO 15189:2022 accreditation
Our laboratory has successfully passed accreditation under the updated ISO 15189:2022 standard. This confirms the compliance of our quality management system with the highest global requirements.
Our laboratory has successfully passed accreditation under the updated ISO 15189:2022 standard. This confirms the compliance of our quality management system with the highest global requirements.
EPL Lab invested in a modern Hamamatsu NanoZoomer S360MD slide scanner for the transition to digital pathology. Telemedicine consultations and archiving are now at a new level.
Our laboratory has successfully passed accreditation according to international quality standards.
Dr. Andriy Melnyk presented the results of a study on rare dermatological neoplasms at the 38th European Congress of Pathology in Berlin.
Expanding the panel of immunohistochemical markers for more accurate diagnostics.
EPL Lab has expanded the available IHC marker panel to over 150 antibodies, enabling diagnostics of even the most complex cases without referral abroad.
Our specialists presented research results at a conference in Berlin.
EPL Lab signed priority service agreements with five leading private clinics in Kyiv. Partners receive accelerated turnaround times and a personal coordinator.
EPL Lab conducted an educational seminar for oncologists and surgeons on modern capabilities of immunohistochemical diagnostics. Over 80 physicians participated.
The laboratory is equipped with a modern slide scanner for digital pathology.
EPL Lab signed cooperation agreements with five leading city clinics.
EPL Lab implemented LEAN management principles in laboratory processes. Result — 25% reduction in sample processing time and decreased preanalytical errors.